USD 0.04
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 8.25 Million USD | -59.02% |
2022 | 27.31 Million USD | 996.72% |
2021 | 2.49 Million USD | -15.55% |
2020 | 2.94 Million USD | 761.5% |
2019 | 342.3 Thousand USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 1.37 Million USD | -12.11% |
2024 Q1 | 1.73 Million USD | 17.09% |
2023 Q3 | 2.12 Million USD | -29.0% |
2023 FY | 11.19 Million USD | -59.02% |
2023 Q4 | 1.48 Million USD | -30.17% |
2023 Q1 | 2.61 Million USD | 60.34% |
2023 Q2 | 2.98 Million USD | 14.31% |
2022 Q2 | 12.88 Million USD | 1673.69% |
2022 Q1 | 726.34 Thousand USD | -21.16% |
2022 FY | 27.31 Million USD | 996.72% |
2022 Q4 | 1.62 Million USD | -71.79% |
2022 Q3 | 5.77 Million USD | -55.16% |
2021 Q4 | 921.29 Thousand USD | 46.65% |
2021 FY | 2.49 Million USD | -15.55% |
2021 Q3 | 628.21 Thousand USD | 45.6% |
2021 Q2 | 431.47 Thousand USD | -15.32% |
2021 Q1 | 509.54 Thousand USD | -26.57% |
2020 FY | 2.94 Million USD | 761.5% |
2020 Q4 | 693.93 Thousand USD | -43.7% |
2020 Q3 | 1.23 Million USD | 101.29% |
2020 Q2 | 612.31 Thousand USD | 8.73% |
2020 Q1 | 563.15 Thousand USD | 0.0% |
2019 FY | 342.3 Thousand USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
BioQuest Corp. | 89.76 USD | -9194276.114% |
Clever Leaves Holdings Inc. | 21.16 Million USD | 61.014% |
Eagle Pharmaceuticals, Inc. | 140.71 Million USD | 94.135% |
Guardion Health Sciences, Inc. | 9.73 Million USD | 15.188% |
GSRX Industries Inc. | - USD | -Infinity% |
High Sierra Technologies, Inc. | 238.36 Thousand USD | -3362.298% |
Instadose Pharma Corp. | - USD | -Infinity% |